The Implant Melting Pot

Dutch company Orthometals recycles and melts down implants left behind after cremation.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Knee replacementFLICKR, MIKE BAIRD

Medical implants, such as knee replacements, artificial hips, and titanium pins, have become increasingly common to help fix ailing joints and mend breaks. But what happens to those implants after patients have passed? Until recently, these metals were probably discarded. But Dutch company Orthometals is looking to change that.

It’s a bit macabre, but the owners collect discarded implants after cremation, melt them down, and recycle the metals by selling them as scrap. The company recycles more than 250 tons of metal annually. And, while cremations rates are higher in the Netherlands, the company isn’t alone.

"I know the existence of five or six competitors that we have, most of them in the United States," Orthometals cofounder Ruud Verberne told BBC News.

Stay tuned for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Hannah Waters

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development